Sort
30,917 grants matching “tumor microenvironment”
Role of Integrins and bone matrix in prostate cancer
$281,501Tatiana V Byzova · Cleveland Clinic Lerner Com-Cwru · R01 · FY2011 · CA
Prostate Oncology
$281,493Max S. Wicha · University Of Michigan At Ann Arbor · P30 · FY2016 · CA
Targeting immunosuppression blockade to T cells for cancer immunotherapy
$281,457Darrell J Irvine · Massachusetts Institute Of Technology · R01 · FY2013 · CA
Systemic Inhibition of Monocyte Chemoattractant Protein-1 (MCP-1; CCL2)
$281,447Robert Loberg · University Of Michigan At Ann Arbor · P50 · FY2012 · CA
Tak1, a novel prostate cancer tumor suppressor
$281,438Scott D Cramer · University Of Colorado Denver · R01 · FY2013 · CA
Project 4 - Study of KSHV Carcinogenesis
$281,390Dirk P Dittmer · Univ Of North Carolina Chapel Hill · P01 · FY2020 · CA
ENDOTHELIAL GROWTH FACTOR IN PROSTATE CANCER METASTASIS
$281,385University Of Virginia Charlottesville · R01 · FY2004 · CA
ENDOTHELIAL GROWTH FACTOR IN PROSTATE CANCER METASTASIS
$281,385University Of Virginia Charlottesville · R01 · FY2001 · CA
ENDOTHELIAL GROWTH FACTOR IN PROSTATE CANCER METASTASIS
$281,385University Of Virginia Charlottesville · R01 · FY2003 · CA
ENDOTHELIAL GROWTH FACTOR IN PROSTATE CANCER METASTASIS
$281,385University Of Virginia Charlottesville · R01 · FY2002 · CA
Biomarker-Driven Strategies to Overcome Immunotherapy Resistance in STK11-Deficient NSCLC
$281,370Jacob Marcus Kaufman · Ohio State University · K08 · FY2024 · CA
Biomarker-Driven Strategies to Overcome Immunotherapy Resistance in STK11-Deficient NSCLC
$281,370Jacob Marcus Kaufman · Ohio State University · K08 · FY2025 · CA
Spatial patterning of branching morphogenesis
$281,362Celeste M Nelson · Princeton University · R01 · FY2012 · GM
Enhancing Radiation Therapy: Vascular Targeting Agents
$281,312Dietmar W Siemann · University Of Florida · R01 · FY2007 · CA
Integrating innate and adaptive immunity in cancer therapy
$281,279Nejat K Egilmez · State University Of New York At Buffalo · R01 · FY2013 · CA
Mechanisms Determining Stromal Pten Suppression of IVIammary Tumorigenesis
$281,249Michael C Ostrowski · Ohio State University · P01 · FY2013 · CA
Suppression of Mammary Tumorigenesis by Stromal p53
$281,241Gustavo Walter Leone · Ohio State University · P01 · FY2013 · CA
Shaping the Microenvironment by DPEP1 Facilitates Adenoma Progression
$281,177Robert J Coffey · Vanderbilt University Medical Center · U54 · FY2025 · CA
Co-Evolution Mechanisms of Pre-Cancer-Immune Interactions in Shaping Adaptive Cytotoxicity and Myeloid-Derived Suppression
$281,177Ken S Lau · Vanderbilt University Medical Center · U54 · FY2025 · CA
Gene product delivery by engineered somatic cells
$281,105Joy A Phillips · Sidney Kimmel Cancer Center · R21 · FY2007 · EB
Project 2: Heparan Sulfate Proteoglycans in Prostate Cancer Bone Metastasis
$281,091Mary C Farach-Carson · Cedars-Sinai Medical Center · P01 · FY2017 · CA
Regulation of Fibronectin Matrix Assembly by uPAR
$281,080Paula J Mc Keown-Longo · Albany Medical College · R01 · FY2010 · CA
Regulation of Fibronectin Matrix Assembly by uPAR
$281,080Paula J Mc Keown-Longo · Albany Medical College · R01 · FY2009 · CA
SUBNUCLEAR TARGETING AND TRANSCRPTIONAL CONTROL DURING INTERPHASE AND MITOSIS IN
$281,070Gary S. Stein · Univ Of Massachusetts Med Sch Worcester · P01 · FY2007 · CA
Enabling NF-kB Signal Transduction Studies in Primary Multiple Myeloma Cells
$281,059Shigeki Miyamoto · University Of Wisconsin-Madison · R01 · FY2012 · CA